Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Steven W. Fleming"'
Autor:
David F. Abbott, Richard A. J. Masterton, John Stephen Archer, Steven W. Fleming, Aaron E. L. Warren, Graeme D. Jackson
Publikováno v:
Frontiers in Neurology, Vol 5 (2015)
One of the most significant impediments to high-quality EEG recorded in an MRI scanner is subject motion. Availability of motion artefact sensors can substantially improve the quality of the recorded EEG. In the study of epilepsy, it can also dramati
Externí odkaz:
https://doaj.org/article/cf143cf8572840a9a292dd25999df840
Autor:
Kristina Domanski, Steven W Fleming, Joshua DeBord, Hayden Maag, Emily Bouso Raley, Roya Mahana, Brooks Wright
Publikováno v:
Journal of psychoactive drugs. 54(4)
Novel psychoactive substances have emerged as drugs of abuse. 2-Fluorodeschloroketamine (2-FDCK) is a ketamine derivative that can be purchased online for as little as $12 per gram. We report the case of a patient with a history of polysubstance use
Publikováno v:
Baylor University Medical Center Proceedings. 31:303-306
AH-7921 is a synthetic opioid that was developed in the early 1970s. It has resulted in several fatal and nonfatal intoxications, despite not having approval from the US Food and Drug Administration. To date, AH-7921 is listed as a schedule I drug, a
Publikováno v:
Clinical Toxicology. 55:1011-1013
The use of marijuana and cannabis concentrates is increasing, especially following decriminalization in several states. Psychosis and cardiotoxicity have been reported following cannabis use; however, myocardial injury from "dabbing" has not yet been
Autor:
Kevin Cho, Liza Chacko, Zubair M Amin, Saeed K Alzghari, Kerry Anne Rambaran, Steven W. Fleming
Publikováno v:
Cureus
Increased experimentation with easily accessible synthetic opioids is posing a hazard to the public. We discuss one such synthetic opioid, U-50488. Much is unknown about U-50488; however, due to its structural similarity to U-47700, there is possible
Publikováno v:
Cureus
Synthetic opioid use continues to be a problem in the United States. New designer opioids continue to be released as "research chemicals" by vendors, leading to widespread use and potentially devastating consequences. U-49900 is a new synthetic opioi
Autor:
Saeed K Alzghari, Steven W. Fleming, Jakub Furmaga, Jie An, Samantha Burkhart, A. Michael Spiekerman, Kerry Anne Rambaran, Kurt C. Kleinschmidt
Publikováno v:
The Journal of emergency medicine. 53(4)
Background U-47700 is a synthetic opioid developed by The Upjohn Company in the 1970s, which has recently appeared in the news and medical literature due to its toxicity. Currently, there are no clinical trial data assessing the safety of U-47700. Ob
Autor:
Steven W. Fleming, A Menendez, Joann Schulte, K Tavakoli, Kristina Domanski, Kurt C. Kleinschmidt, C. Clinton Frazee Iii
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 55(1)
Novel substances often referred to as "designer drugs" have emerged as drugs of abuse, and recognition of these is difficult as routine blood and urine screening tests do not detect these agents. U-47700 is a synthetic selective μ-opioid agonist tha
Publikováno v:
Forensic Science Policy & Management: An International Journal. 2:158-163
In counties with limited budgets, in order to save money on toxicology work, the request often comes from local medical examiners that screening for drugs on decedents be performed initially on urine and, if positive, to send blood for confirmation;
Publikováno v:
Journal of Forensic Sciences. 56:1376-1379
This case represents unusual findings of elevated bupivacaine and tryptase concentrations following local anesthetic, bupivacaine, administered as a scalene nerve block for elective rotator cuff repair surgery. Following bupivacaine injection, the pa